Mark Leid and Theresa Filtz, with collaborators at Erasmus University Medical Center, University of Leicester, University of Oxford, and the Skeletal Biology Laboratory at Oregon State published in Human Molecular Genetics A de novo substitution in BCL11B leads to loss of interaction with transcriptional complexes and craniosynostosis.
Gadusol Laboratories is developing a nontoxic sunscreen using gadusol, a substance that fish and other marine life use to avoid sunburn. Read more!
Gut microbial metabolism of xanthohumol produces estrogenic metabolites, notably 8‐prenylnaringenin. In article number 1800923, Jan F. Stevens and co‐workers show that 8‐prenylnaringenin is not the end product of metabolism by gut microbes, shedding new light on the perceived pro‐estrogenicity of xanthohumol. Read more!
CORVALLIS, Ore. – Oregon State University researchers studying cervical cancer have identified a bacterium that helps the disease spread, opening up a potential new target for treating cervical and other cancers. The findings are important because more than 8 million women worldwide receive cancer diagnoses annually. Nearly 7 percent of the cases are cervical cancer. […]
3D skin generation technology replaces human testing. After bringing the dermatology to campus for the first time in 2005, the Indras have developed extensive collaborations in the college and with different colleges on campus, and are now collaborating with researchers and clinicians at OHSU and Knight Cancer Institute in Portland.
Research led by co-corresponding authors Aleksandra Sikora of Oregon State University and Nicholas Noinaj of Purdue University provides key structural and functional insights into a multicomponent protein complex known as BAM, short for beta-barrel assembly machinery. Featured in the news.